Patients who already qualify for GLP-1 therapy and would like additional support Individuals with suboptimal B12 levels or risk of deficiency Those who prefer combining metabolic and micronutrient therapy Patients fully committed to close medical oversight and follow-up However, its not recommended if you have contraindications to GLP-1 agents, are pregnant, breastfeeding, have uncontrolled GI disease, or cannot adhere to monitoring and follow-up
12th Meeting International Society of Haematology:45, 1993
Migraine aura During the 12-hour observational period following the start of CGRP infusion, 13 (38%) of 34 participants experienced migraine aura (Table 2)
Red Blood Cell Formation Like folate, erythroblasts require vitamin B12 for proliferation during their differentiation
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy
